Biosimilars: Safe, Effective, & May Reduce Patient Costs

MLN Connects newsletter for Thursday, May 19, 2022

News

• Biosimilars: Safe, Effective, & May Reduce Patient Costs
• PECOS Scroll Functionality
• Clinical Laboratory Improvement Amendments: Unpaid Certificate Fees
• Quarterly Update to the Medicare Physician Fee Schedule Database (MPFSDB)
• Mental Health: Help Address Disparities

Compliance

• Collaborative Patient Care is a Provider Partnership

MLN Matters® Articles

• Elimination of Certificates of Medical Necessity & Durable Medical Equipment Information Forms
• International Classification of Diseases, 10th Revision (ICD-10) and Other Coding Revisions to National Coverage Determination (NCDs)-October 2022 Update
• Revisions to Medicare Part B Coverage of Pneumococcal Vaccinations for the Medicare Benefit Policy Manual Chapter 15, Section 50.4.4.2

Publications

• Chronic Care Management Services - Revised
• Home Health Quality Reporting Program: Draft OASIS-E Guidance Manual